SCHEMBL21332824

SCHEMBL21332824

CC(=O)Nc1ccc(=O)n(CC(=O)c2cc(C)n(Cc3ccccc3)c2C)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR2 O95136 4/20 0.67
▸ SMN1; SMN2 Q16637 6/20 0.56
▸ ALDH1A1 P00352 5/20 0.56
▸ TSHR P16473 4/20 0.56
▸ NOTUM Q6P988 1/20 0.52
▸ KMT2A Q03164 4/20 0.50
▸ RAB9A P51151 4/20 0.47
▸ LMNA P02545 4/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ TP53 P04637 2/20 0.47
▸ NR2F2 P24468 2/20 0.47
▸ POLB P06746 1/20 0.47
▸ MAPT P10636 5/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ TAAR1 Q96RJ0 1/20 0.47
▸ KLKB1 P03952 2/20 0.44
▸ PLA2G1B P04054 1/20 0.44
▸ ATG4B Q9Y4P1 1/20 0.44
▸ KLK1 P06870 1/20 0.43
▸ NPC1 O15118 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21339690 0.85 S1PR2 (0.75) S1PR2SMN1; SMN2ALDH1A1TSHRNOTUM
SCHEMBL21332935 0.84 S1PR2 (0.74) S1PR2SMN1; SMN2ALDH1A1TSHRNOTUM
SCHEMBL21333146 0.83 S1PR2 (0.72) S1PR2SMN1; SMN2ALDH1A1TSHRNOTUM
SCHEMBL21333708 0.83 S1PR2 (0.72) S1PR2SMN1; SMN2ALDH1A1TSHRNOTUM
SCHEMBL22831377 0.83 S1PR2 (0.72) S1PR2SMN1; SMN2ALDH1A1TSHRNOTUM
SCHEMBL22831374 0.82 S1PR2 (0.67) S1PR2SMN1; SMN2ALDH1A1TSHRNOTUM
SCHEMBL21333428 0.81 S1PR2 (0.70) S1PR2SMN1; SMN2ALDH1A1TSHRNOTUM
SCHEMBL21333209 0.81 S1PR2 (0.83) S1PR2SMN1; SMN2ALDH1A1TSHRNOTUM
SCHEMBL21332286 0.80 S1PR2 (0.68) S1PR2SMN1; SMN2ALDH1A1TSHRNOTUM
SCHEMBL21333503 0.80 S1PR2 (0.68) S1PR2SMN1; SMN2ALDH1A1TSHRNOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3762377-B1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND MEDICAL USES THEREOF UNIV CORNELL (US) 2025-08-20 — — EP disclosed
US-11964960-B2 Pyridinone- and pyridazinone-based compounds and uses thereof CORNELL UNIVERSITY (US) 2024-04-23 — — US disclosed
EP-3762377-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND MEDICAL USES THEREOF Cook, Timothy, H. (US) 2021-01-13 — — EP disclosed
US-20200407339-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND USES THEREOF TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE 2020-12-31 — — US disclosed
US-20200407339-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND USES THEREOF TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE 2020-12-31 — — US disclosed
WO-2019173790-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND MEDICAL USES THEREOF HLA TIMOTHY (US) 2019-09-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200407339-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND USES THEREOF PTGER1, LOXL1, COL1A1 S1PR2 601/4885SMN1; SMN2 3979/4885ALDH1A1 421/4885
US-11964960-B2 Pyridinone- and pyridazinone-based compounds and uses thereof PTGER1, LOXL1, COL1A1 S1PR2 601/4885SMN1; SMN2 3979/4885ALDH1A1 421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback